ALEXANDER SUSAN H

SEC source: 0001127602-23-002477 · form4.xml · nonDerivative · entry 1

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,099

F1 · shares: Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 12, 2020. The shares will vest on February 12, 2023.

SEC source: 0001127602-22-024470 · form4.xml · nonDerivative · entry 1

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,396

F1 · kind: Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001209191-22-023051 · doc4.xml · nonDerivative · entry 1

ALEXANDER SUSAN H · CIK 0001263839 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,499

F1 · shares: Restricted stock units granted pursuant to the Invacare Corporation 2018 Equity Compensation Plan in an exempt transaction under Rule 16b-3. These restricted stock units vest in full on May 15, 2023.

F2 · balance_after: Includes 13,388 previously reported restricted stock units issued pursuant to the Invacare Corporation 2018 Equity Compensation Plan, all of which vest in full on May 15, 2022.

SEC source: 0001127602-22-006262 · form4.xml · derivative · entry 4

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,248

Underlying: Common Stock · 2,137 shares

Expires 2024-02-18

F2 · kind: This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested.

F1 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date]).

SEC source: 0001127602-22-006262 · form4.xml · derivative · entry 3

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,385

Underlying: Common Stock · 1,485 shares

Expires 2024-02-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date]).

SEC source: 0001127602-22-006262 · form4.xml · nonDerivative · entry 2

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,928

SEC source: 0001127602-22-006262 · form4.xml · nonDerivative · entry 1

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,587

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-22-004993 · form4.xml · derivative · entry 9

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,218

Underlying: Common Stock · 2,090 shares

Expires 2023-02-12

F3 · kind: This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested.

F2 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]).

SEC source: 0001127602-22-004993 · form4.xml · derivative · entry 8

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,308

Underlying: Common Stock · 1,126 shares

Expires 2023-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]).

SEC source: 0001127602-22-004993 · form4.xml · derivative · entry 7

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,190 shares

Expires 2022-02-12

F3 · kind: This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested.

F2 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]).

SEC source: 0001127602-22-004993 · form4.xml · derivative · entry 6

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,190

Underlying: Common Stock · 1,154 shares

Expires 2022-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]).

SEC source: 0001127602-22-004993 · form4.xml · nonDerivative · entry 5

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,102

F1 · kind: Represents shares withheld to satisfy the withholding tax liability due upon vesting of shares, as previously disclosed by reporting person on January 21, 2022.

SEC source: 0001127602-22-004993 · form4.xml · nonDerivative · entry 4

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,146

SEC source: 0001127602-22-004993 · form4.xml · nonDerivative · entry 3

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,646

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-22-004993 · form4.xml · nonDerivative · entry 2

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,520

SEC source: 0001127602-22-004993 · form4.xml · nonDerivative · entry 1

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,032

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-22-004811 · form4.xml · derivative · entry 2

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,725

Underlying: Common Stock · 7,725 shares

Expires 2025-02-10

F1 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022.

SEC source: 0001127602-22-001858 · form4.xml · nonDerivative · entry 2

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,878

F1 · shares: Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 12, 2019. The shares will vest on February 12, 2022.

SEC source: 0001127602-22-001858 · form4.xml · nonDerivative · entry 1

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,053

SEC source: 0001209191-21-020835 · doc4.xml · nonDerivative · entry 1

ALEXANDER SUSAN H · CIK 0001263839 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,025

F1 · shares: Restricted stock units granted pursuant to the Invacare Corporation 2018 Equity Compensation Plan in an exempt transaction under Rule 16b-3. These restricted stock units vest in full on May 15, 2022.

F2 · balance_after: Includes 15,439 previously reported restricted stock units issued pursuant to the Invacare Corporation 2018 Equity Compensation Plan, all of which vest in full on May 15, 2021.

SEC source: 0001127602-21-006970 · form4.xml · derivative · entry 1

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,870

Underlying: Common Stock · 10,870 shares

Expires 2024-02-18

F1 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]).

SEC source: 0001127602-21-006261 · form4.xml · derivative · entry 13

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,434

Underlying: Common Stock · 1,367 shares

Expires 2023-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date]).

SEC source: 0001127602-21-006261 · form4.xml · derivative · entry 12

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,801

Underlying: Common Stock · 1,849 shares

Expires 2023-02-12

F3 · kind: This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested.

F2 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date]).

SEC source: 0001127602-21-006261 · form4.xml · derivative · entry 11

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,344

Underlying: Common Stock · 1,402 shares

Expires 2022-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date]).

SEC source: 0001127602-21-006261 · form4.xml · derivative · entry 10

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,746

Underlying: Common Stock · 1,936 shares

Expires 2022-02-12

F3 · kind: This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested.

F2 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date]).

SEC source: 0001127602-21-006261 · form4.xml · derivative · entry 9

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,788 shares

Expires 2021-02-12

F3 · kind: This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested.

F2 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date]).

SEC source: 0001127602-21-006261 · form4.xml · derivative · entry 8

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,788

Underlying: Common Stock · 1,586 shares

Expires 2021-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date]).

SEC source: 0001127602-21-006261 · form4.xml · nonDerivative · entry 7

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,576

SEC source: 0001127602-21-006261 · form4.xml · nonDerivative · entry 6

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,183

SEC source: 0001127602-21-006261 · form4.xml · nonDerivative · entry 5

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,805

SEC source: 0001127602-21-006261 · form4.xml · nonDerivative · entry 4

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,509

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-21-006261 · form4.xml · nonDerivative · entry 3

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,142

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-21-006261 · form4.xml · nonDerivative · entry 2

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,740

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-21-006261 · form4.xml · nonDerivative · entry 1

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,154

F1 · kind: Represents shares withheld to satisfy the withholding tax liability due upon the vesting of shares, as previously disclosed by reporting person on January 29, 2021.

SEC source: 0001127602-21-002980 · form4.xml · nonDerivative · entry 1

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,117

F1 · shares: Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 12, 2018. The shares will vest on February 12, 2021.

SEC source: 0001209191-20-021855 · doc4.xml · nonDerivative · entry 1

ALEXANDER SUSAN H · CIK 0001263839 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,637

F1 · shares: Restricted stock units granted pursuant to the Invacare Corporation 2018 Equity Compensation Plan in an exempt transaction under Rule 16b-3. These restricted stock units vest in full on May 15, 2021.

F2 · balance_after: Includes 18,045 previously reported restricted stock units issued pursuant to the Invacare Corporation 2018 Equity Compensation Plan, all of which vest in full on May 15, 2020.

SEC source: 0001127602-20-006544 · form4.xml · derivative · entry 4

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,171 shares

Expires 2020-02-15

F2 · shares: This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested.

F1 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date]).

SEC source: 0001127602-20-006544 · form4.xml · derivative · entry 3

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,171

Underlying: Common Stock · 1,553 shares

Expires 2020-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date]).

SEC source: 0001127602-20-006544 · form4.xml · nonDerivative · entry 2

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,572

SEC source: 0001127602-20-006544 · form4.xml · nonDerivative · entry 1

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,261

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-20-005772 · form4.xml · derivative · entry 12

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,682

Underlying: Common Stock · 1,803 shares

Expires 2022-02-12

F2 · shares: This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested.

F1 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]).

SEC source: 0001127602-20-005772 · form4.xml · derivative · entry 11

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,485

Underlying: Common Stock · 1,535 shares

Expires 2022-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]).

SEC source: 0001127602-20-005772 · form4.xml · derivative · entry 10

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,697 shares

Expires 2020-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The restricted stock units will vest in 2 annual installments. One-third will vest on the first anniversary of the grant date and two-thirds will vest on the second anniversary of the grant date.

SEC source: 0001127602-20-005772 · form4.xml · derivative · entry 9

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,374

Underlying: Common Stock · 1,633 shares

Expires 2021-02-12

F2 · shares: This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested.

F1 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]).

SEC source: 0001127602-20-005772 · form4.xml · derivative · entry 8

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,007

Underlying: Common Stock · 1,735 shares

Expires 2021-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]).

SEC source: 0001127602-20-005772 · form4.xml · derivative · entry 7

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,650

Underlying: Common Stock · 9,650 shares

Expires 2023-02-12

F1 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]).

SEC source: 0001127602-20-005772 · form4.xml · nonDerivative · entry 6

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,708

SEC source: 0001127602-20-005772 · form4.xml · nonDerivative · entry 5

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,389

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-20-005772 · form4.xml · nonDerivative · entry 4

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,854

SEC source: 0001127602-20-005772 · form4.xml · nonDerivative · entry 3

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Off & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,652

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.